SLU-PP-332: uses, dosing & the facts

A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.

By OptiPin Editorial·Last updated July 2026

Status

Research use only · not FDA-approved. Reported dosing below reflects community-discussed patterns, presented for information only — not a dose recommendation. For the US regulatory picture on research peptides, see the 2026 FDA compounding status.

Class

Fat loss

Used for

Muscle endurance enhancement

Half-life

Approximately 4-6 ho…

Status

Research use only

TL;DR

• SLU-PP-332 — Fat loss. A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.
• Commonly used for muscle endurance enhancement, strength and performance, metabolic function support.
• Half-life: Approximately 4-6 hours.
• Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.

What SLU-PP-332 is

A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.

What SLU-PP-332 is used for

• Muscle endurance enhancement
• Strength and performance
• Metabolic function support
• Exercise capacity improvement
• Athletic performance
• Body recomposition

These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.

Typical reported dosing

Oral	100-500mcg taken orally daily, typically 1-2 hours before training

Presented as commonly-reported patterns for information only — not a dose recommendation. SLU-PP-332 dosing is a decision for a qualified clinician.

Half-life & cycling

Half-life: Approximately 4-6 hours. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.

Cycling

Can be used continuously during training periods. Typical cycles: 8-12 weeks on, 4 weeks off.

Side effects & warnings

• Generally well-tolerated
• Limited safety data available
• Possible mild gastrointestinal effects

Research use only. Very new research compound. Limited human data available. Oral administration is convenient. May enhance exercise performance. Start with lower doses. Take before workouts for best results. Not technically a peptide but often grouped with research peptides.

Not a prescription, a dose, or a sourcing guide. SLU-PP-332 is a research compound; safety and efficacy in humans are not fully established, and research-grade material has no guarantee of purity, sterility, or stated strength. OptiPin is a tracking tool and does not recommend using research chemicals. Discuss any peptide with a qualified clinician.

Tracking SLU-PP-332 in OptiPin

If you're tracking a SLU-PP-332 protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.

Track it properly

Log doses, outcomes & vials in OptiPin

Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.

Download on the App Store

FAQ

What is SLU-PP-332?

A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.

What is SLU-PP-332 used for?

Commonly discussed uses include: muscle endurance enhancement, strength and performance, metabolic function support, exercise capacity improvement, athletic performance, body recomposition. These are reported uses, not proven outcomes or a recommendation.

How is SLU-PP-332 dosed?

Commonly reported dosing: Oral — 100-500mcg taken orally daily, typically 1-2 hours before training. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — SLU-PP-332 is not an approved medicine and dosing should involve a qualified clinician.

What is SLU-PP-332's half-life?

Approximately 4-6 hours. Half-life shapes how often it is dosed and how quickly it clears.

What are SLU-PP-332's side effects?

Reported effects include: generally well-tolerated, limited safety data available, possible mild gastrointestinal effects. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.

Educational only, not medical advice. SLU-PP-332 is a research compound and is not an approved medicine for the uses described. OptiPin is a tracking tool and does not provide dosing or treatment advice. Discuss any peptide with a qualified clinician.

Evidence & further reading

Search the peer-reviewed literature for SLU-PP-332 on PubMed (entry point to the primary evidence base, not a specific citation).
SLU-PP-332 on ClinicalTrials.gov — registered human trials, if any.
US FDA / 503A compounding status of research peptides (2026).
OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.

Tesofensine · 5-Amino-1MQ · AOD-9604 · BAM-15 · Tirzepatide (Mounjaro/Zepbound) · Reconstitution calculator · All peptides